Osteomalacia is a metabolic bone disorder characterized by the softening and weakening of bones due to impaired mineralization of the bone matrix, particularly with insufficient mineralization of hydroxyapatite. The primary cause is often a deficiency in vitamin D, which plays a crucial role in calcium absorption and bone mineralization. Other factors contributing to osteomalacia include inadequate dietary intake of calcium and phosphorus, certain medical conditions affecting kidney function, or gastrointestinal disorders interfering with nutrient absorption. Common symptoms include bone pain, muscle weakness, and an increased risk of fractures. Laboratory tests revealing low levels of serum calcium, phosphorus, and vitamin D, along with elevated alkaline phosphatase, aid in diagnosis. Treatment involves addressing the underlying cause, often with vitamin D and calcium supplementation. Lifestyle modifications, such as increased sun exposure and dietary adjustments, may also be recommended. Early detection and appropriate management are crucial to prevent further bone deterioration and improve the overall bone health of individuals with osteomalacia.